Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Aug;7(4):271-6.
doi: 10.1111/j.1742-481X.2010.00690.x. Epub 2010 May 28.

A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns

Affiliations
Randomized Controlled Trial

A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns

Pornprom Muangman et al. Int Wound J. 2010 Aug.

Abstract

Silver sulfadiazine has been used as a topical burn wound treatment for many years. Pain associated with dressing changes is a common problem in burn wounds. Aquacel Ag, a hydrofiber dressing coated with ionic silver has been reported to reduce burn wound infection and promote antimicrobial activity. The purpose of this study was to show the benefits of Aquacel Ag for the treatment of partial thickness burns. This prospective randomized study was conducted in 70 patients who had partial thickness burns less than 15% of total body surface area and were treated at Siriraj outpatient burn clinic during December 2006-February 2008. Patients were divided into two groups: Aquacel Ag-treated group with dressing changes every 3 days (35 patients) and 1% silver sulfadiazine-treated group, with daily dressing changes (35 patients). There was no difference in demographic data including age, gender, burn percentage between groups. Time-to-wound healing pain score during dressing change and cost of treatment were compared between both groups. Time-to-wound closure was significantly shorter in the Aquacel Ag-treated group (10 +/- 3 versus 13.7 +/- 4 days, P < 0.02) as well as pain scores at days 1, 3 and 7 (4.1 +/- 2.1, 2.1 +/- 1.8, 0.9 +/- 1.4 versus 6.1 +/- 2.3, 5.2 +/- 2.1, 3.3 +/- 1.9, respectively, P < 0.02). Total cost of treatment was 52 +/- 29 US dollars for the Aquacel Ag-treated group versus 93 +/- 36 US dollars for the silver sulfadiazine-treated group. This study showed that Aquacel Ag increased time to healing, decreased pain symptoms and increased patient convenience because of limiting the frequency of replacement of the dressing at lower total cost. This study confirms the efficacy of Aquacel Ag for the treatment of partial thickness burns at an outpatient clinic.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Time of wound healing.
Figure 2
Figure 2
Cumulative wound healing of both the treated groups.
Figure 3
Figure 3
Average pain scores in Aquacel® Ag and silver sulfadiazine‐treated group.

Similar articles

Cited by

References

    1. Caruso DM, Foster KN, Hermans MH, Rick C. Aquacel® Ag in the management of partial‐thickness burns: results of a clinical trial. J Burn Care Rehabil 2004; 25:89–97. - PubMed
    1. Muangman P, Chuntrasakul C, Silthram S, Suvanchote S, Benjathanung R, Kittidacha S, Rueksomtawin S. Comparison of efficacy of 1% silver sulfadiazine and Acticoat® for treatment of partial thickness burn wounds. J Med Assoc Thai 2006;89:953–8. - PubMed
    1. Twomey JA, Caruso D, Silverstein P, Antimarino J, Bauer G, Blome‐Eberwein SA, Herndon D, Luterman A. Randomized controlled study of silver dressing effects on partial‐thickness burn outcomes [abstract P58]. Plast Reconstr Surg 2005;116(Suppl 3):194. - PubMed
    1. Barnea Y, Amir A, Leshem D, Zaretski A, Weiss J, Shafir R, Gur E. Clinical comparative study of Aquacel® and paraffin gauze dressing for split‐skin donor site treatment. Ann Plast Surg 2004;53:132–6. - PubMed
    1. Mooney E, Lippitt C, Friedman J. Silver dressings. Plast Reconstr Surg 2006;117:666–9. - PubMed

Publication types

MeSH terms

Substances